Executive Director, International Strategy
Forest Laboratories, Inc. - New York, NY

This job posting is no longer available on Forest Laboratories, Inc.. Find similar jobs:Executive Director jobs - Forest Laboratories jobs

Our Company

Forest Laboratories, Inc. (FLI) is an innovative, growth-oriented prescription pharmaceutical company focused on developing top-quality therapies that help people lead healthier, more fulfilling lives. We take pride in meeting our business objectives and expanding our product franchises, but we also derive satisfaction in helping to bring relief to people who are suffering. Our products treat conditions such as depression, anxiety, Alzheimer’s disease, hypertension and fibromyalgia, and we keep a focused eye on the future with a robust pipeline of compounds at virtually every stage of development. With headquarters in New York City and operations in New Jersey, Long Island, Missouri, Ohio, California, Ireland and the U.K, each of Forest’s more than 5,000 employees contributes to our quest to deliver quality products with entrepreneurial spirit, unflagging integrity and deep respect for people and community. Explore your potential to thrive with a career at Forest.

This executive staff position focuses on both the strategic and operational needs of Forest’s growing international business. The Executive Director will either directly manage or partner with international business executives in growing their respective businesses. Additionally, the Executive Director will work with the VP of International Business Strategy and Operations (IBSO) in the creation and continuous evolution of Forest’s international strategy; while leading the global cross function product or market assessment teams.

  • Along with the VP of IBSO, the Executive Director will partner with the Head of Forest’s European business to support the further expansion of that business.

  • The Executive Director will work to lead the development of projections for any partnered or out-licensed international rights.

  • The Executive Director will work with the VP of IBSO and the IBSO team to review new strategies or business opportunities for our international affiliates, such as acquisition of new product rights or businesses. New business opportunities may be global, regional or local in scope and the Executive Director would need to lead the assessment of the business and strategic rationale for such deals and their impact on the applicable regions by working with the affiliates and various functions within the organization to understand all aspects of the new opportunity, including the potential development and regulatory pathway as well as the commercial potential. In all cases, close alignment with the Business Development group, as well as the Global Marketing, New Products and Scientific Assessment groups with be important.

  • The Executive Director would help develop the strategy for the international rights to our products. This will require evaluating the specific value proposition on a market-by-market basis working closely with Global Marketing and the International function within the Research Institute, and with affiliates where applicable, and then deciding whether those rights are worth exploiting. If so, then further evaluation of the best way to optimize that value will be needed, this may include consideration of retaining rights for ourselves, or partnering and/or out-licensing such rights. If it is decided to partner or our-license such rights, the Executive Director would work closely with the Business Development group for partnering or licensing of these international rights.

  • The Executive Director would work closely with the Alliance Management group on, any partnership that includes international rights for Forest. This will require regular senior level contact with our partners as well as participation in joint governance committees where applicable. Together with the Alliance Management group, the Executive Director will need to make sure that such partnerships are operating smoothly and also ensure that our partners are in compliance with all contractual obligations with respect to our products.

  • The Executive Director, together with the Strategic Planning group, would develop Forest’s international strategy. Such strategy may include expansion of Forest’s international business, which would require a full evaluation of other markets, and the consideration of various possible means to access markets determined to be of interest. In such cases, the pros and cons – from both an economic return and operational perspective – of direct expansion, joint venture, acquisition or other strategic partnership should all be considered.

Position Requirements

  • An Undergraduate degree is required.

  • An MBA or other relevant advanced business or finance degree is highly preferred.

  • A minimum of 15 years of business experience is required.

  • A minimum of 10 years of hands-on in international regulated business experience in the Pharmaceutical or Medical Device industry is required.

  • A minimum of 10 years of strategic and/or operational oversight of one or more business functions is required.

  • Ex-US work experience is required; preference will be given to country experience in the following regions: LATAN, EU, or emerging markets.

  • Specific pharmaceutical industry experience with licensing partners strongly preferred.

Knowledge, Skills, and Abilities:
  • Strong intellectual capability with high degree of entrepreneurial initiative is required.

  • The ability to synthesize and complete analysis of a high volume of complex data is required.

  • Strong leadership and influencing skills, with superb listening and team collaboration work style is required.

  • The ability to travel 40% of the time including internationally is required.

  • This individual must be highly organized and able to manage heavy and diverse workload on a regular basis.

About this company
114 reviews
Forest Laboratories doesn't just blend in with the trees. The company develops and manufactures prescription drugs to address a wide...